Drug intelligence / Profile preview

recombinant human lipoprotein lipase

Development stage
Unknown
Lead developer
uniQure
Modality
Therapeutic Enzymes → Recombinant Proteins and Enzymes
01

Overview

Recombinant human lipoprotein lipase is a protein produced through genetic engineering that mimics the function of naturally occurring human lipoprotein lipase (LPL). LPL is a crucial enzyme in triglyceride metabolism, responsible for the hydrolysis of triglycerides from circulating chylomicrons and very low-density lipoproteins (VLDLs) into free fatty acids and monoacylglycerols. This process is essential for lipid clearance from the bloodstream, lipid utilization, and storage. Deficiency in LPL, often due to genetic mutations, leads to severe hypertriglyceridemia and conditions like lipoprotein lipase deficiency (LPLD), which can cause recurrent pancreatitis and other cardiovascular complications. While the recombinant protein itself is primarily available as a research reagent, therapeutic strategies have focused on restoring LPL activity, most notably through gene therapies that deliver the LPL gene to enable the body to produce functional enzyme.

Other names
Lipoprotein LipaseLPLLIPDHDLCQ11HDLCQ-11HDLCQ 11
02

Targets

HSPG (Basement membrane-specific heparan sulfate proteoglycan core protein (perlecan))GPIHBP1

Beyond the preview

Go deeper on recombinant human lipoprotein lipase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on recombinant human lipoprotein lipase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call